ALEXANDRIA, Va., March 5 -- United States Patent no. 12,239,664, issued on March 4, was assigned to GENENTECH INC. (South San Francisco, Calif.).
"Efficient TCR gene editing in T lymphocytes" was invented by Sascha Rutz (San Francisco), Benjamin Joseph Haley (San Francisco), Shravan Madireddi (Fremont, Calif.), Soyoung Oh (San Bruno, Calif.), David Shaw (Burlingame, Calif.) and Kate Halliwell Senger (Oakland, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to engineered T cells and methods of making and using the same, as well as reagents for making the engineered T cells."
The patent was filed on March 24, 2022, under Application No. 17/703,927.
*For further informatio...